Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer

Data for this study is retreived from routine cinical care and the CABO-ASAP study. The use of the patient data in future research is possible after a renewed permission by the patient as recorded in the informed consent (CABO-ASAP) or after permission of the ethics committee of Radboudumc. Original data is stored at H:\Vakgroep\Onderzoek\ONCO\AFGERONDE STUDIES\ONCO_CABOZANTINIB\Data analyse CABO SGC MRCC 2021